CURIS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.34 USD | +2.19% |
|
+12.53% | +28.16% |
| 02-09 | HC Wainwright Adjusts Price Target on Curis to $26 From $51, Maintains Buy Rating | MT |
| 02-08 | Curis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Curis, Inc.
f.YAg1V0rHX2DftQUypiCpZMMCPQ9BCDRvKdWHLxongT8.N3lPZg6PMAi60l1V4RjhFZB1BGM2UX04Ubv1SFRl9m8MUUYhDKA1DJbcNQ~028a40ddef0768ba264f48d1e3cfeb74
Upcoming events on Curis, Inc.
Past events on Curis, Inc.
| 08/04/2024 17:45 | Needham Healthcare Conference |
| 08/02/2024 13:30 | Q4 2023 Earnings Call |
| 08/02/2024 13:00 | Q4 2023 Earnings Release |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract No - 4497 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract No - 3143 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract No - 2924 |
| 02/11/2023 12:30 | Q3 2023 Earnings Call |
| 02/11/2023 12:00 | Q3 2023 Earnings Release |
| 28/09/2023 | Reverse Split: 1 of 20 |
| 27/09/2023 14:10 | Cantor Global Healthcare Conference |
| 26/09/2023 15:00 | Extraordinary Shareholders Meeting |
| 22/09/2023 14:00 | IRAK4 Symposium |
| 12/09/2023 13:30 | H.C. Wainwright Global Investment Conference |
| 03/08/2023 21:30 | Q2 2023 Earnings Call |
| 03/08/2023 21:01 | Q2 2023 Earnings Release |
| 23/05/2023 15:00 | Annual General Meeting |
| 04/05/2023 21:30 | Q1 2023 Earnings Call |
| 04/05/2023 21:01 | Q1 2023 Earnings Release |
| 20/04/2023 19:15 | Needham Healthcare Conference |
| 05/04/2023 17:00 | Cantor The Future of Oncology Virtual Symposium - Panel |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 10,8 10,6 1.96% | 10,6 10,7 -0.25% | 10,2 10,4 -2.56% | 10,0 10,3 -2.9% | 8,61 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -41,9 -40,0 -4.77% | -52,8 -54,0 2.25% | 0,00 0,00 - | -49,3 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -24,9 -23,8 -4.58% | -42,1 -40,4 -4.21% | -53,0 -54,0 1.75% | -48,3 -48,1 -0.49% | -50,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -29,9 -28,9 -3.37% | -45,4 -43,8 -3.77% | -56,7 -57,2 0.96% | -47,4 -48,7 2.6% | -49,2 |
|
Net income Million USD | Released Forecast Spread | -32,1 | -29,9 -28,8 -3.81% | -45,4 -43,8 -3.77% | -56,7 -57,6 1.55% | -47,4 -48,7 2.66% | -49,6 |
|
EPS USD | Released Forecast Spread | -19,4 | -12,2 -11,9 -2.23% | -10,0 -9,56 -4.6% | -12,2 -12,4 1.61% | -8,96 -6,85 -30.76% | -6,21 |
| Announcement Date | 19/03/20 | 16/03/21 | 24/02/22 | 13/03/23 | 08/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,14 2,93 6.93% | 2,06 2,55 -19.31% | 2,39 2,72 -12.09% | 2,83 3,16 -10.56% | 2,89 3,26 -11.35% | 2,30 2,59 -11.22% | 2,20 2,51 -12.63% | 2,83 2,63 7.92% | 2,70 3,08 -12.58% | 2,00 | 2,03 | 2,27 | 2,29 | 2,65 |
|
EBITDA Million USD | Released Forecast Spread | -12,5 -11,0 -13.9% | -15,1 -14,6 -3.4% | -15,0 -15,0 -0.05% | -12,5 -15,0 16.37% | -10,1 -12,0 15.6% | -11,6 -9,94 -16.33% | -12,1 -11,6 -4.45% | -12,3 -11,6 -6.44% | -12,4 | -12,6 | -12,1 | -12,3 | -13,8 | |
|
EBIT Million USD | Released Forecast Spread | -12,6 -11,0 -14.57% | -15,1 -13,7 -10.66% | -15,1 -14,5 -3.76% | -12,6 -14,5 13.2% | -10,2 -11,4 10.05% | -11,6 -9,51 -22.33% | -12,1 -11,1 -9.42% | -12,4 -11,5 -7.99% | -12,2 -12,3 0.67% | -12,7 | -12,7 | -12,5 | -12,6 | -12,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,6 -11,9 -14.22% | -16,1 -14,7 -9.36% | -15,9 -15,2 -4.92% | -13,3 -15,4 13.89% | -11,3 -12,0 5.54% | -11,6 -10,5 -10.24% | -12,0 -11,9 -0.46% | -12,2 -12,1 -0.38% | -11,7 -12,1 3.32% | -12,6 | -12,7 | -12,0 | -11,9 | -12,9 |
|
Net income Million USD | Released Forecast Spread | -13,6 -11,9 -14.13% | -16,1 -14,7 -9.37% | -15,9 -15,3 -4.04% | -13,3 -15,5 14.27% | -11,3 -12,3 7.92% | -11,6 -10,5 -10.15% | -12,0 -11,8 -1.55% | -12,2 -12,1 -0.75% | -11,7 -12,3 4.99% | -12,6 | -12,6 | -12,2 | -12,3 | -12,9 |
|
EPS USD | Released Forecast Spread | -3,00 -2,56 -17.19% | -3,60 -3,20 -12.5% | -3,40 -3,30 -3.03% | -2,80 -3,40 17.65% | -2,40 -2,55 5.88% | -2,40 -2,15 -11.63% | -2,40 -2,35 -2.13% | -2,13 -2,36 9.65% | -2,03 -2,12 4.25% | -2,05 | -1,72 | -1,42 | -1,38 | -1,20 |
| Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 09/11/22 | 13/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 08/02/24 | - | - | - | - | - |
More events
Past sector events for Curis, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRIS Stock
- Calendar Curis, Inc.
